nodgoРоссийский журнал детской гематологии и онкологии (РЖДГиО)Russian Journal of Pediatric Hematology and Oncology2311-12672413-5496LTD “Graphica”10.17650/2311-1267-2017-4-1-77-80nodgo-285Research ArticleВОПРОСЫ ПРАКТИЧЕСКОЙ ГЕМАТОЛОГИИ-ОНКОЛОГИИQUESTIONS OF PRACTICAL HEMATOLOGY/ONCOLOGYСовременные аспекты диагностики и лечения патологии гемостаза на основе опыта французского центраModern aspects of diagnosis and treatment of diseases of hemostasis based on the French center experienceФедороваД. В.FedorovaD. V.

117997, Москва, ул. Саморы Машела, 1

1 Samory Mashela St., Moscow, 117997

darya.v.fedorova@gmail.comФГБУ «ННПЦ ДГОИ им. Дмитрия Рогачева» Минздрава РоссииРоссияDmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Ministry of Health of RussiaRussian Federation201701032017417780Copyright © Федорова Д.В., 20172017Федорова Д.В.Fedorova D.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.nodgo.org/jour/article/view/285

В настоящее время проблема тромбоцитопений и тромбоцитопатий, а также патология гемостаза в целом является важным вопросом, который представляет собой интересную тему, актуальную для всех детских гематологов и онкологов. Одним из лидеров направления в изучении данного вопроса является Госпиталь Тимон в г. Марсель (Франция), передовой опыт которого представлен в статье победителя конкурса на лучшее представление клинического случая, проводимого Национальным обществом детских гематологов и онкологов.

Now the problem thrombocytopenia and thrombocytopathy and pathology of hemostasis in general is an important issue, which is an interesting topic, relevant for all children’s hematology and oncology. One of the leading trends in the study of this issue is Timon Hospital in Marseilles (France), of which the best practices presented in the article, the winner for the best presentation of clinical cases, held by the National Society of Pediatric Hematology and Oncology.

детитромбоцитопениитромбоцитопатииновые технологииchildrenthrombocytopeniathrombocytopathynew technologiesReferencesGresele P.; Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015;13(2):314–22.Gresele P.; Subcommittee on Platelet Physiology of the International Society on Thrombosis and Hemostasis. Diagnosis of inherited platelet function disorders: guidance from the SSC of the ISTH. J Thromb Haemost 2015;13(2):314–22.Dovlatova N. Current status and future prospects for platelet function testing in the diagnosis of inherited bleeding disorders. Br J Haematol 2015;170(2):150–61.Dovlatova N. Current status and future prospects for platelet function testing in the diagnosis of inherited bleeding disorders. Br J Haematol 2015;170(2):150–61.Watson S.P., Lowe G.C., Lordkipanidzé M., Morgan N.V.; GAPP consortium. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost 2013;11 Suppl 1:351–63.Watson S.P., Lowe G.C., Lordkipanidzé M., Morgan N.V.; GAPP consortium. Genotyping and phenotyping of platelet function disorders. J Thromb Haemost 2013;11 Suppl 1:351–63.Bolton-Maggs P.H., Chalmers E.A., Collins P.W. et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006;135(5):603–33.Bolton-Maggs P.H., Chalmers E.A., Collins P.W. et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006;135(5):603–33.Boender J., Kruip M.J., Leebeek F. A diagnostic approach to mild bleeding disorders. J Thromb Haemost 2016;14(8): 1507–16.Boender J., Kruip M.J., Leebeek F. A diagnostic approach to mild bleeding disorders. J Thromb Haemost 2016;14(8): 1507–16.Gresele P., Bury L., Falcinelli E. Inherited Platelet Function Disorders : Algorithms for Phenotypic and Genetic Investigation. Semin Thromb Hemost 2016;42(3):292–305.Gresele P., Bury L., Falcinelli E. Inherited Platelet Function Disorders : Algorithms for Phenotypic and Genetic Investigation. Semin Thromb Hemost 2016;42(3):292–305.Daly M.E., Leo V.C., Lowe G.C. What is the role of genetic testing in the investigation of patients with suspected platelet function disorders? Br J Haematol 2014;165(2):193–203.Daly M.E., Leo V.C., Lowe G.C. What is the role of genetic testing in the investigation of patients with suspected platelet function disorders? Br J Haematol 2014;165(2):193–203.Lentaigne C., Freson K., Laffan M.A. et al.; BRIDGE-BPD Consortium and the ThromboGenomics Consortium. Inherited platelet disorders: toward DNA-based diagnosis. Blood 2016;127(23):2814–23.Lentaigne C., Freson K., Laffan M.A. et al.; BRIDGE-BPD Consortium and the ThromboGenomics Consortium. Inherited platelet disorders: toward DNA-based diagnosis. Blood 2016;127(23):2814–23.Canault M., Ghalloussi D., Grosdidier C. et al. Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med 2014;211(7):1349–62.Canault M., Ghalloussi D., Grosdidier C. et al. Human CalDAG-GEFI gene (RASGRP2) mutation affects platelet function and causes severe bleeding. J Exp Med 2014;211(7):1349–62.Fressinaud E., Dieval J., Gay V. et al. A National Multicenter Prospective Cohort for Congenital Bleeding Disorders. Blood 2005;106(11):4094.Fressinaud E., Dieval J., Gay V. et al. A National Multicenter Prospective Cohort for Congenital Bleeding Disorders. Blood 2005;106(11):4094.http://www.francecoag.org [cited 2017 Jan 10].http://www.francecoag.org [cited 2017 Jan 10].Quiroga T., Mezzano D. Is my patient a bleeder ? A diagnostic framework for mild bleeding disorders. Hematology Am Soc Hematol Educ Program 2012;2012:466–474.Quiroga T., Mezzano D. Is my patient a bleeder ? A diagnostic framework for mild bleeding disorders. Hematology Am Soc Hematol Educ Program 2012;2012:466–474.http://www.maladies-plaquettes.org/fr/pathologies-plaquettaires/registre-renapp/24.html [cited 2017 Jan 10].http://www.maladies-plaquettes.org/fr/pathologies-plaquettaires/registre-renapp/24.html [cited 2017 Jan 10].Srivastava A., Brewer A.K., Mauser-Bunschoten E.P. et al. Guidelines for the management of hemophilia. Haemophilia 2013;19(1):e1–47.Srivastava A., Brewer A.K., Mauser-Bunschoten E.P. et al. Guidelines for the management of hemophilia. Haemophilia 2013;19(1):e1–47.Laffan M.A., Lester W., O’Donnell J.S. et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014;167(4):453–65.Laffan M.A., Lester W., O’Donnell J.S. et al. The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology. Br J Haematol 2014;167(4):453–65.

The authors declare that there are no conflicts of interest present.